Prescription Drug Discussion Forums  

Go Back   Prescription Drug Discussion Forums > Medication Discussions > Specific Drug Discussions > Velcade


Thread Tools Display Modes
Old 06-07-2005, 05:00 AM
Susan Rose
Posts: n/a
Default Velcade and RLS

I have just finished my third cycle of Velcade treating multiple myeloma, Lambda Light Chain. I had a remarkable clinical response after the first cycle but now the cancer is progressing again. The worst side effect for me is exaserbation of Restless Legs Syndrome which I have had a serious case for years. I take Mirapex to control it, but even at high dosage I am having severe episodes. Does anyone have this problem? Also, I am thinking of adding low dose oral cytoxin to the Velcade to increase the efficacy. Has anyone done that?
Reply With Quote


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Velcade Diane Velcade 0 09-13-2007 03:46 PM
VELCADE JTHOMAS Velcade 0 08-19-2007 11:31 PM
Availablity of Velcade Harish Gupta Velcade 1 12-03-2005 06:00 AM
velcade Unregistered Velcade 0 07-05-2005 05:00 AM
velcade Lee Velcade 0 05-25-2005 05:00 AM

This site is presented as an educational source only. The information on this site is not a substitute for a visit with your doctor or pharmacist. Always talk to your doctor before changing medications or dosage, or if you experience any serious side effects. The information on this site that has been contributed by other visitors should be taken with a grain of salt. This is the Internet and you have no idea if the person who posted any information knows what they are talking about. Use this site to come up with a list of questions to ask your doctor, do not use this site to replace your doctor.

All times are GMT. The time now is 12:04 AM.

Powered by vBulletin® Version 3.8.8
Copyright ©2000 - 2022, vBulletin Solutions, Inc.